Cargando…

IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators

Pulmonary fibrosis is a hallmark of diseases such as systemic sclerosis (SSc, scleroderma) and idiopathic pulmonary fibrosis (IPF). To date, the therapeutic options for patients with pulmonary fibrosis are limited, and organ transplantation remains the most effective option. Insulin-like growth fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Xinh-Xinh, Muhammad, Lutfiyya, Nietert, Paul J., Feghali-Bostwick, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196226/ https://www.ncbi.nlm.nih.gov/pubmed/30374330 http://dx.doi.org/10.3389/fendo.2018.00601

Ejemplares similares

Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2021)

Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2020)

2027 The role of lysyl oxidase in systemic sclerosis-associated lung fibrosis
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2018)

Insulin‐like growth factor binding protein‐4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C‐X‐C chemokine receptor 4
por: Su, YunYun, et al.
Publicado: (2019)

IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF
por: Su, Yunyun, et al.
Publicado: (2015)

Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis
por: van de Vlekkert, Diantha, et al.
Publicado: (2019)

E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
por: Sharma, Shailza, et al.
Publicado: (2021)

Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5
por: Yamaguchi, Yukie, et al.
Publicado: (2011)

The Membrane-Associated Adaptor Protein DOK5 Is Upregulated in Systemic Sclerosis and Associated with IGFBP-5-Induced Fibrosis
por: Yasuoka, Hidekata, et al.
Publicado: (2014)

Hyperleptinemia in Neonatally Overfed Female Rats Does Not Dysregulate Feeding Circuitry
por: Ziko, Ilvana, et al.
Publicado: (2017)

Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis
por: Aida-Yasuoka, Keiko, et al.
Publicado: (2013)

Increased Concentrations of Insulin-Like Growth Factor Binding Protein (IGFBP)-2, IGFBP-3, and IGFBP-4 Are Associated With Fetal Mortality in Pregnant Cows
por: Mense, Kirsten, et al.
Publicado: (2018)

Fibroblasts in fibrosis: novel roles and mediators
por: Kendall, Ryan T., et al.
Publicado: (2014)

Human Skin Culture as an Ex Vivo Model for Assessing the Fibrotic Effects of Insulin-Like Growth Factor Binding Proteins
por: Yasuoka, Hidekata, et al.
Publicado: (2008)

The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis
por: Mouawad, Joe E., et al.
Publicado: (2023)

Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide
por: Perks, Claire M., et al.
Publicado: (2011)

Systems Analysis of Transcriptomic and Proteomic Profiles Identifies Novel Regulation of Fibrotic Programs by miRNAs in Pulmonary Fibrosis Fibroblasts
por: Mullenbrock, Steven, et al.
Publicado: (2018)

382 The Role of the IL-6-IGF-II Axis in Systemic Sclerosis-Associated Lung Fibrosis
por: Adewale, Adegboyega Timothy, et al.
Publicado: (2023)

Low Baseline Expression of Fibrotic Genes in an Ex Vivo Human Skin Model is a Potential Indicator of Excessive Skin Scarring
por: Mouawad, Joe E., et al.
Publicado: (2022)

Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2021)

Insulin-Like Growth Factor Binding Proteins-3 and -5: Central Mediators of Fibrosis and Promising New Therapeutic Targets
por: Veraldi, Kristen L, et al.
Publicado: (2012)

Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is K(Ca)3.1-dependent
por: Roach, Katy M, et al.
Publicado: (2014)

Potential Functions of IGFBP-2 for Ovarian Folliculogenesis and Steroidogenesis
por: Spitschak, Marion, et al.
Publicado: (2018)

Biological effects and regulation of IGFBP5 in breast cancer
por: Dittmer, Jürgen
Publicado: (2022)

IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation
por: Zheng, Yan, et al.
Publicado: (2020)

Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates
por: Hoeflich, Andreas, et al.
Publicado: (2014)

Dissemination of novel biostatistics methods: Impact of programming code availability and other characteristics on article citations
por: Wahlquist, Amy E., et al.
Publicado: (2018)

The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease
por: Stuard, Whitney L., et al.
Publicado: (2020)

Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease
por: Takahashi, Shin-Ichiro, et al.
Publicado: (2022)

Elucidating the cellular mechanism for E2-induced dermal fibrosis
por: Baker Frost, DeAnna, et al.
Publicado: (2021)

Pro-fibrotic SNPs
por: Maxmen, Amy
Publicado: (2009)

Peripheral Hybrid CB(1)R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis
por: Zawatsky, Charles N., et al.
Publicado: (2021)

Editorial: Current Perspectives on Insulin-Like Growth Factor Binding Protein (IGFBP) Research
por: Hoeflich, Andreas, et al.
Publicado: (2018)

IGFBP-2 Signaling in the Brain: From Brain Development to Higher Order Brain Functions
por: Khan, Shumsuzzaman
Publicado: (2019)

Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetes
por: Brismar, Kerstin, et al.
Publicado: (2023)

IGF-I and IGFBP-1 in Relation to Body Composition and Physical Performance in Female Olympic Athletes
por: Eklund, Emma, et al.
Publicado: (2021)

Fasting Serum IGFBP-1 as a Marker of Insulin Resistance in Diverse School Age Groups
por: Bhangoo, Amrit, et al.
Publicado: (2022)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

Glutamate Pays Its Own Way in Astrocytes
por: McKenna, Mary C.
Publicado: (2013)

Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
por: Garrett, Sara M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4mhrl7kl0mtcsmt7bdf5lkgb6r